BANGKOK, July 2 (Bloomberg): Thailand won’t be able to meet its monthly vaccination target of 10 million doses as deliveries from AstraZeneca Plc, the backbone of its inoculation programme, will be 40% to 50% fewer than expected because some supplies are allotted for export.
AstraZeneca will deliver 5 million to 6 million doses per month for use in Thailand starting in July because a portion of local production by Siam Bioscience Ltd, its manufacturing partner in South-East Asia, will be shipped to other countries in the region, Nakorn Premsri, director of the National Vaccine Institute, said at a seminar on Friday, citing a letter from the company.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
